Radiopharmaceutical Products

Potential saving opportunities 6% - on some products ex generators

Reference: SBS/20/BH/DT/10025

Framework Agreement Description

The Radiopharmaceutical Products Framework Agreement provides radiopharmaceutical materials, maintenance, support and training from a carefully selected range of qualified suppliers. This framework covers radiopharmaceutical kits, diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals. Also covered under this framework agreement for radiopharmaceutical products, are a range of generators including krypton, technetium and gallium.

Download the Framework Flyer

Radiopharmaceutical Products (PDF) [200KB]

Framework Agreement Information

When does the framework agreement start?
01 April 2021 until 31 March 2024 - with the option to extend for a further 12 months

Who can take advantage of the radiopharmaceutical products framework agreement?
All NHS SBS Approved Organisations. This includes all Public Sector Organisations in the UK.

What does the framework agreement cover?
A wide range of radiopharmaceutical products including:
• radiopharmaceutical kits
• diagnostic radiopharmaceuticals
• therapeutic radiopharmaceuticals
• technetium generators
• krypton generators
• 18F -FDG

The awarded suppliers are also able to provide training, maintenance and support where required.

What are the benefits of the framework agreement?
• OJEU COMPLIANT
A detailed procurement exercise has taken place to ensure that suppliers selected are appropriate in terms of meeting all legislative requirements and therefore no formal tendering is required, saving valuable time and money in the procurement process.
• SIMPLIFIED ORDERING PROCESS
Ability to view suppliers through GHX/NEXUS, which supports the ordering and payment process.
• CONTRACT MANAGEMENT & SUPPORT
Supplier performance and spend is monitored on an ongoing basis by NHS SBS. We are available to support Customers with any problems which may arise during the course of the framework agreement.
• CLINICALLY COMPLIANT
All products comply with the Medical Devices Directive 93/42/EEC.
• MINI-COMPETITION AND DIRECT AWARD
Both direct award and mini-competition routes to market are available.
• DELIVERY OPTIONS AVAILABLE
Direct delivery option to all approved organisations.
• FLEXIBLE AND AGILE
New products and innovations can be added to the framework agreement scope.